Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Bichet

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Molecular Genetics and Metabolism|December 22, 2009
Baseline characteristics of patients enrolled in the Canadian Fabry Disease InitiativeS Sirrs, J T R Clarke, D G Bichet, et al.
Circulation Research|March 1, 1985
Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansionK M Nicholls, M D Shapiro, V J Van Putten, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta)L B Kinter, I McConnell, B T Goodwin, et al.
American Journal of Human Genetics|August 1, 1994
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidusD G Bichet, M Birnbaumer, M Lonergan, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
Hyponatremia in cirrhosis: from pathogenesis to treatmentP Ginés, T Berl, M Bernardi, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1993
Gs-activating receptors: modes of transmembrane signalling and genetic defectsW Rosenthal, T Gudermann, A Antaramian, et al.
American Journal of Human Genetics|November 1, 1992
X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studiesD G Bichet, G N Hendy, M Lonergan, et al.
Anesthesia and Analgesia|August 10, 1999
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changesC Mann, G Boccara, Y Pouzeratte, et al.
Biochemistry|June 8, 2001
Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidusJ P Morello, A Salahpour, U E Petäjä-Repo, et al.
The Journal of Clinical Investigation|April 5, 2000
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutantsJ P Morello, A Salahpour, A Laperrière, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Molecular Genetics and Metabolism|December 22, 2009
Baseline characteristics of patients enrolled in the Canadian Fabry Disease InitiativeS Sirrs, J T R Clarke, D G Bichet, et al.
Circulation Research|March 1, 1985
Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansionK M Nicholls, M D Shapiro, V J Van Putten, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta)L B Kinter, I McConnell, B T Goodwin, et al.
American Journal of Human Genetics|August 1, 1994
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidusD G Bichet, M Birnbaumer, M Lonergan, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
Hyponatremia in cirrhosis: from pathogenesis to treatmentP Ginés, T Berl, M Bernardi, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1993
Gs-activating receptors: modes of transmembrane signalling and genetic defectsW Rosenthal, T Gudermann, A Antaramian, et al.
American Journal of Human Genetics|November 1, 1992
X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studiesD G Bichet, G N Hendy, M Lonergan, et al.
Anesthesia and Analgesia|August 10, 1999
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changesC Mann, G Boccara, Y Pouzeratte, et al.
Biochemistry|June 8, 2001
Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidusJ P Morello, A Salahpour, U E Petäjä-Repo, et al.
The Journal of Clinical Investigation|April 5, 2000
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutantsJ P Morello, A Salahpour, A Laperrière, et al.
Pageof 8